Literature DB >> 19245789

Upregulated expression of miR-1/miR-206 in a rat model of myocardial infarction.

Zhi-Xin Shan1, Qiu-Xiong Lin, Yong-Heng Fu, Chun-Yu Deng, Zhi-Ling Zhou, Jie-Ning Zhu, Xiao-Ying Liu, You-Yi Zhang, Yangxin Li, Shu-Guang Lin, Xi-Yong Yu.   

Abstract

MicroRNAs (miRNAs) have been increasingly reported to have important roles in diverse biological and pathological processes. We investigated miR-1 and miR-206 expression and their potential roles in a rat model of myocardial infarction (MI). miR-1 and miR-206 expression were significantly increased, and insulin-like growth factor 1 (IGF-1) protein was markedly reduced without obvious change of its mRNA level after MI induction. Position 175-196 of rat IGF-1 3'-untranslated region was identified to be required for efficient downregulation by miR-1/miR-206. IGF-1 level was reduced without changing its transcript level in rat H9C2 myoblast cells modified with miR-1 (H9C2-miR-1). In the serum withdrawal and hypoxic condition, caspase-3 activity and mitochondrial potential were significantly increased in H9C2-miR-1 cells compared with the control group, respectively (p<0.05, p<0.01). Together, our results indicate that miR-1 and miR-206 are involved in apoptotic cell death in MI by post-transcriptional repression of IGF-1.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19245789     DOI: 10.1016/j.bbrc.2009.02.097

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  96 in total

1.  Post-transcriptional regulation of IGF1R by key microRNAs in long-lived mutant mice.

Authors:  Ruqiang Liang; Amit Khanna; Senthilkumar Muthusamy; Na Li; Harshini Sarojini; John J Kopchick; Michal M Masternak; Andrzej Bartke; Eugenia Wang
Journal:  Aging Cell       Date:  2011-12       Impact factor: 9.304

Review 2.  miRNAs as therapeutic targets in ischemic heart disease.

Authors:  Robert J A Frost; Eva van Rooij
Journal:  J Cardiovasc Transl Res       Date:  2010-03-30       Impact factor: 4.132

Review 3.  Bone marrow mesenchymal stem cells for post-myocardial infarction cardiac repair: microRNAs as novel regulators.

Authors:  Zhuzhi Wen; Shaoxin Zheng; Changqing Zhou; Woliang Yuan; Jingfeng Wang; Tong Wang
Journal:  J Cell Mol Med       Date:  2012-04       Impact factor: 5.310

Review 4.  MicroRNAs: a novel class of potential therapeutic targets for cardiovascular diseases.

Authors:  Zhen-wei Pan; Yan-jie Lu; Bao-feng Yang
Journal:  Acta Pharmacol Sin       Date:  2009-12-07       Impact factor: 6.150

5.  The caspase-8 shRNA-modified mesenchymal stem cells improve the function of infarcted heart.

Authors:  Yeyou Liang; Qiuxiong Lin; Jiening Zhu; Xiaohong Li; Yongheng Fu; Xiao Zou; Xiaoying Liu; Honghong Tan; Chunyu Deng; Xiyong Yu; Zhixin Shan; Weiwei Yuan
Journal:  Mol Cell Biochem       Date:  2014-07-25       Impact factor: 3.396

6.  ES cells overexpressing microRNA-1 attenuate apoptosis in the injured myocardium.

Authors:  Carley Glass; Dinender K Singla
Journal:  Mol Cell Biochem       Date:  2011-06-14       Impact factor: 3.396

Review 7.  MicroRNAs regulate the chaperone network in cerebral ischemia.

Authors:  Yi-Bing Ouyang; Rona G Giffard
Journal:  Transl Stroke Res       Date:  2013-08-17       Impact factor: 6.829

Review 8.  MicroRNAs in myocardial ischemia: identifying new targets and tools for treating heart disease. New frontiers for miR-medicine.

Authors:  V Sala; S Bergerone; S Gatti; S Gallo; A Ponzetto; C Ponzetto; T Crepaldi
Journal:  Cell Mol Life Sci       Date:  2013-11-12       Impact factor: 9.261

9.  The Cardiotoxic Mechanism of Doxorubicin (DOX) and Pegylated Liposomal DOX in Mice Bearing C-26 Colon Carcinoma: a Study Focused on microRNA Role for Toxicity Assessment of New Formulations.

Authors:  Kamal Razavi-Azarkhiavi; Mahmoud Reza Jaafari; Khalil Abnous; Bibi Marjan Razavi; Amir Hossein Jafarian; Faezeh Vahdati Hassani; Kobra Shirani; Gholamreza Karimi
Journal:  Pharm Res       Date:  2017-05-30       Impact factor: 4.200

10.  Effect of intravenous injection of antagomiR-1 on brain ischemia.

Authors:  Anis Talebi; Mehdi Rahnema; Mohammad Reza Bigdeli
Journal:  Mol Biol Rep       Date:  2019-02-01       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.